公开(公告)号：US09271477B2

公开(公告)日：2016-03-01

申请号：US14377594

申请日：2013-02-12

Applicant: CALANUS AS

Inventor： Snorre Angell ,  Remi Mathisen ,  Bjarne Johansen ,  Trond Larsen ,  Kurt Steinar Tande

IPC: A01K61/00

CPC classification number: A01K61/60 ,  A01K61/10 ,  Y02A40/826

Abstract: The present invention relates to a device for isolating farm cages for fish against undesirable organisms, which device is arranged enclosing the farm cage, where the device comprises a fine-meshed fluid-permeable net which is open upwardly and downwardly when arranged round the farm cage, where the fluid-permeable net will extend a distance down in the farm cage's depth direction, in order thereby to form a skirt round the farm cage.

Abstract translation: 本发明涉及一种用于隔离农场笼子以防止不期望的生物体的装置，该装置被布置成围绕农场笼，其中该装置包括细小网状的可透过液体的网，该布网围绕农场笼 其中流体渗透网将在农场笼的深度方向上向下延伸一段距离，从而在农场笼上形成裙部。

公开(公告)号：US09820958B2

公开(公告)日：2017-11-21

申请号：US14305011

申请日：2014-06-16

Applicant: Calanus AS

Inventor： Jan Raa ,  Gunnar Rorstad ,  Kurt Steinar Tande

IPC: A61K31/202 ,  A61K31/122 ,  A61K31/232 ,  A61K31/045 ,  A61K31/201 ,  A61K35/56 ,  A23D9/013 ,  A23L33/115

CPC classification number: A61K31/202 ,  A23D9/013 ,  A23L33/115 ,  A23V2002/00 ,  A61K31/045 ,  A61K31/122 ,  A61K31/201 ,  A61K31/232 ,  A61K35/56 ,  A61K2300/00 ,  A23V2200/326 ,  A23V2200/3262 ,  A23V2250/187 ,  A23V2250/1868

Abstract: This invention relates to a biological oil composition, preferably obtained from a copepod, most preferably the copepod Calanus finmarchicus and the use thereof to prevent or treat formation of atherosclerotic plaques and hence development of coronary heart disease. The composition comprises the same marine n-3 polyunsaturated fatty acids (PUFAs) generally regarded as being responsible for the anti-atherosclerotic effect of marine oils, namely EPA (C20:5n-3 eicosapentaenoic acid) and DHA (C22:6n-3 docosahexaenoic acid). However, quite unexpectedly, it has been found that the oil composition of the present invention has a remarkably higher ability to prevent formation of atherosclerotic plaques than what can be attributed to EPA and DHA alone, and moreover, unlike EPA and DHA alone it has a notable blood cholesterol lowering effect.

公开(公告)号：US20150000606A1

公开(公告)日：2015-01-01

申请号：US14377594

申请日：2013-02-12

Applicant: Calanus AS

Inventor： Snorre Angell ,  Remi Mathisen ,  Bjarne Johansen ,  Trond Larsen ,  Kurt Steinar Tande

IPC: A01K61/00

CPC classification number: A01K61/60 ,  A01K61/10 ,  Y02A40/826

Abstract: The present invention relates to a device for isolating farm cages for fish against undesirable organisms, which device is arranged enclosing the farm cage, where the device comprises a fine-meshed fluid-permeable net which is open upwardly and downwardly when arranged round the farm cage, where the fluid-permeable net will extend a distance down in the farm cage's depth direction, in order thereby to form a skirt round the farm cage.

Abstract translation: 本发明涉及一种用于隔离农场笼子以防止不期望的生物体的装置，该装置被布置成围绕农场笼，其中该装置包括细小网状的可透过液体的网，该布网围绕农场笼 其中流体渗透网将在农场笼的深度方向上向下延伸一段距离，从而在农场笼上形成裙部。

公开(公告)号：US20180352832A1

公开(公告)日：2018-12-13

申请号：US15578009

申请日：2016-05-27

Applicant: Calanus AS

Inventor： Gunnar Rørstad ,  Hogne Abrahamsen ,  Kurt Tande

IPC: A23J1/04 ,  A23K20/147 ,  A23K50/48 ,  A23J3/04 ,  A23J3/34 ,  A23L33/18

CPC classification number: A23J1/04 ,  A23J3/04 ,  A23J3/30 ,  A23J3/347 ,  A23K20/147 ,  A23K50/40 ,  A23K50/48 ,  A23L17/00 ,  A23L23/00 ,  A23L29/275 ,  A23L33/18 ,  A23V2002/00

Abstract: The present invention concerns novel protein hydrolysates of marine origin and methods of producing the same. The invention also concerns the use of such hydrolysates as palatants and as a food flavoring agents.

公开(公告)号：US20140302128A1

公开(公告)日：2014-10-09

申请号：US14305011

申请日：2014-06-16

Applicant: Calanus AS

Inventor： Jan Raa ,  Gunnar Rorstad ,  Kurt Steinar Tande

IPC: A61K31/202 ,  A61K31/045 ,  A61K31/201 ,  A61K31/122 ,  A61K35/56

CPC classification number: A61K31/202 ,  A23D9/013 ,  A23L33/115 ,  A23V2002/00 ,  A61K31/045 ,  A61K31/122 ,  A61K31/201 ,  A61K31/232 ,  A61K35/56 ,  A61K2300/00 ,  A23V2200/326 ,  A23V2200/3262 ,  A23V2250/187 ,  A23V2250/1868

Abstract: This invention relates to a biological oil composition, preferably obtained from a copepod, most preferably the copepod Calanus finmarchicus and the use thereof to prevent or treat formation of atherosclerotic plaques and hence development of coronary heart disease. The composition comprises the same marine n-3 polyunsaturated fatty acids (PUFAs) generally regarded as being responsible for the anti-atherosclerotic effect of marine oils, namely EPA (C20:5n-3 eicosapentaenoic acid) and DHA (C22:6n-3 docosahexaenoic acid). However, quite unexpectedly, it has been found that the oil composition of the present invention has a remarkably higher ability to prevent formation of atherosclerotic plaques than what can be attributed to EPA and DHA alone, and moreover, unlike EPA and DHA alone it has a notable blood cholesterol lowering effect.

Abstract translation: 本发明涉及一种生物油组合物，优选由桡足类，最优选桡足类Calanus finmarchicus获得，以及其用于预防或治疗动脉粥样硬化斑块形成以及冠状动脉心脏病发展的用途。 该组合物包含通常被认为负责海洋油的抗动脉粥样硬化作用的相同的海洋n-3多不饱和脂肪酸（PUFA），即EPA（C20：5n-3二十碳五烯酸）和DHA（C22：6n-3二十二碳六烯酸 酸）。 然而，非常出乎意料地，已经发现本发明的油组合物具有显着更高的阻止形成动脉粥样硬化斑块的能力，而不仅仅是EPA和DHA可归因于EPA和DHA，而且与单独的EPA和DHA不同，它具有 显着的降胆固醇降低作用。

公开(公告)号：US20140105999A1

公开(公告)日：2014-04-17

申请号：US14141492

申请日：2013-12-27

Applicant: Calanus AS

Inventor： Jan Raa ,  Gunnar Rorstad ,  Kurt Steinar Tande

IPC: A61K31/201 ,  A61K35/64

CPC classification number: A61K31/201 ,  A23D9/013 ,  A23K20/158 ,  A23L33/115 ,  A23L33/12 ,  A23L33/30 ,  A23V2002/00 ,  A61K31/122 ,  A61K31/202 ,  A61K31/231 ,  A61K31/232 ,  A61K35/612 ,  A61K35/63 ,  A61K35/64 ,  A61K2300/00 ,  A23V2250/1882

Abstract: This invention relates to an oil composition, preferably obtained from a copepod, and the use thereof to reduce accumulation of visceral fat and counteract impairment of heart function caused by obesity inducing Western diets. The oil composition of the present invention can thus be used to reduce abdominal obesity and improve glucose tolerance and thus to reduce the risk of obesity related diseases such as but not limited to type 2 diabetes or cardiovascular disease, or to prevent or treat such diseases.

Abstract translation: 本发明涉及一种优选由桡足类获得的油组合物及其用于减少内脏脂肪积累并抵抗由引起西方饮食引起的肥胖引起的心脏功能损伤的用途。 因此，本发明的油组合物可用于减少腹部肥胖并改善葡萄糖耐量，从而降低肥胖相关疾病（例如但不限于2型糖尿病或心血管疾病）的风险，或用于预防或治疗这些疾病。